iRhythm Technologies Feed

	Est. tid*
2027-04-30	22:05	Kvartalsrapport 2027-Q1
2027-02-19	N/A	Bokslutskommuniké 2026
2026-10-30	22:05	Kvartalsrapport 2026-Q3
2026-07-31	22:05	Kvartalsrapport 2026-Q2
2026-05-27	-	Årsstämma
2026-04-30	-	Kvartalsrapport 2026-Q1
2026-02-19	-	Bokslutskommuniké 2025
2025-10-30	-	Kvartalsrapport 2025-Q3
2025-07-31	-	Kvartalsrapport 2025-Q2
2025-05-28	-	Årsstämma
2025-05-02	-	Kvartalsrapport 2025-Q1
2025-02-21	-	Bokslutskommuniké 2024
2024-10-31	-	Kvartalsrapport 2024-Q3
2024-08-02	-	Kvartalsrapport 2024-Q2
2024-05-29	-	Årsstämma
2024-05-03	-	Kvartalsrapport 2024-Q1
2024-02-23	-	Bokslutskommuniké 2023
2023-11-03	-	Kvartalsrapport 2023-Q3
2023-08-04	-	Kvartalsrapport 2023-Q2
2023-05-24	-	Årsstämma
2023-05-05	-	Kvartalsrapport 2023-Q1
2023-02-23	-	Bokslutskommuniké 2022
2022-11-04	-	Kvartalsrapport 2022-Q3
2022-08-05	-	Kvartalsrapport 2022-Q2
2022-05-26	-	Årsstämma
2022-05-06	-	Kvartalsrapport 2022-Q1
2022-02-28	-	Bokslutskommuniké 2021
2021-11-05	-	Kvartalsrapport 2021-Q3
2021-08-09	-	Kvartalsrapport 2021-Q2
2021-06-18	-	Årsstämma
2021-05-10	-	Kvartalsrapport 2021-Q1
2021-02-26	-	Bokslutskommuniké 2020
2020-11-06	-	Kvartalsrapport 2020-Q3
2020-08-07	-	Kvartalsrapport 2020-Q2
2020-06-19	-	Årsstämma
2020-05-08	-	Kvartalsrapport 2020-Q1
2019-07-31	-	Kvartalsrapport 2019-Q2
2019-05-22	-	Årsstämma
2019-05-07	-	Kvartalsrapport 2019-Q1

Land	USA
Sektor	Hälsovård
Industri	Medicinteknik

2026-05-19 22:05:00 iRhythm Holdings to Participate in Upcoming Investor Conferences 115,55 USD | +0,71%

2026-04-30 22:05:00 iRhythm Holdings Announces First Quarter 2026 Financial Results 119,32 USD | -7,36%

2026-04-27 14:05:00 New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy 127,26 USD | +3,67%

2026-04-16 22:05:00 iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026 127,38 USD | +4,60%

2026-03-30 14:05:00 Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform 118,91 USD | +0,55%

2026-03-12 21:30:00 iRhythm Holdings Appoints Jason Patten to its Board of Directors 113,69 USD | -1,45%

2026-02-19 22:05:00 iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results 150,96 USD | -4,98%

2026-02-05 22:30:00 iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 146,47 USD | -0,19%

2026-01-12 13:30:00 iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference 168,99 USD | -5,82%

2025-12-29 22:30:00 iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference 178,57 USD | -0,02%

2025-11-21 14:10:00 New Data at the Asia Pacific Heart Rhythm Society (APHRS) 2025 Highlight the Performance of iRhythm’s Zio Long-Term Continuous Monitoring in an Asian Population 177,82 USD | +4,78%

2025-11-21 14:10:00 第18回アジア太平洋不整脈学会学術大会（APHRS2025）で発表された新たなデータにより　アジア人集団におけるiRhythm社のZio長期連続モニタリングの性能が明らかに 177,82 USD | +4,78%

2025-11-11 14:05:00 iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025 176,31 USD | +0,01%

2025-11-04 22:30:00 iRhythm Technologies to Participate in Upcoming Investor Conferences 180,49 USD | -0,34%

2025-10-30 21:05:00 iRhythm Technologies Announces Third Quarter 2025 Financial Results 187,30 USD | +1,73%

2025-10-16 22:30:00 iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025 181,80 USD | +0,43%

2025-08-29 13:00:02 AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies’ Zio LTCM Service 169,98 USD | -0,87%

2025-08-20 22:30:00 iRhythm Technologies to Participate in Upcoming Investor Conferences 166,68 USD | +2,13%

2025-08-18 14:05:00 AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm’s Zio LTCM Clinical Superiority 157,93 USD | -1,65%

2025-07-31 22:10:00 iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions 164,97 USD | +17,68%

2025-07-31 22:05:00 iRhythm Technologies Announces Second Quarter 2025 Financial Results 164,97 USD | +17,68%

2025-07-17 22:30:00 iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025 136,24 USD | +0,35%

2025-07-07 14:30:00 iRhythm Technologies Announces Board Member Retirements and New Director Appointments 139,22 USD | -2,28%

2025-06-23 14:30:00 New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease 150,95 USD | +3,57%

2025-05-21 22:45:00 iRhythm Technologies to Participate in Upcoming Investor Conferences 142,44 USD | +1,84%

2025-05-01 22:10:00 iRhythmは、日本においてZio ECG記録・解析システムとしてZio®長期連続モニタリング　サービスを開始し、AIを活用した不整脈検出の進化を推進します。 131,12 USD | +20,75%

2025-05-01 22:10:00 iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection 131,12 USD | +20,75%

2025-04-30 00:05:00 iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference 106,89 USD | +0,23%

2025-04-28 14:05:00 iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring 106,64 USD | +0,61%

2025-04-17 22:30:00 iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025 101,77 USD | +0,17%

2025-04-16 14:35:00 iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability 99,95 USD | -0,79%

2025-03-31 14:05:00 iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection 104,68 USD | -0,30%

2025-02-20 22:05:00 iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results 119,44 USD | +6,01%

2025-02-06 22:05:00 iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025 110,00 USD | +1,34%

2025-01-13 14:30:00 iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference 94,59 USD | -3,18%

2024-12-30 22:30:00 iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference 90,17 USD | +3,74%

2024-11-20 22:30:00 iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference 73,90 USD | +0,22%

2024-11-18 14:15:00 iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring 76,86 USD | -4,46%

2024-11-05 22:30:00 iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference 89,50 USD | +3,25%

2024-10-30 22:15:08 iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device 72,44 USD | -4,39%

2024-10-30 21:08:07 iRhythm Technologies Announces Third Quarter 2024 Financial Results 72,44 USD | -4,39%

2024-10-28 13:02:00 Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy 76,30 USD | +0,82%

2024-10-21 22:05:28 iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device 75,59 USD | +21,72%

2024-10-16 22:05:00 iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024 62,49 USD | +1,17%

2024-09-11 14:05:00 iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence 74,83 USD | +3,34%

2024-09-09 14:05:00 iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting 69,98 USD | +4,14%

2024-09-04 13:30:00 iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring 68,98 USD | +1,44%

2024-09-01 19:33:00 iRhythm Technologies Announces Results of GUARD-AF Trial

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

iRhythm Technologies

Kalender

Beskrivning

Vem äger bolaget?

iRhythm Technologies

Kalender

Beskrivning

Vem äger bolaget?

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden